Sino Biopharmaceutical Limited (FRA:SMZ1)

Sino Biopharmaceutical Revenue

In the year 2024, Sino Biopharmaceutical had annual revenue of 28.87B CNY with 10.18% growth. Sino Biopharmaceutical had revenue of 12.99B in the half year ending December 31, 2024.

• Revenue: 28.87B CNY
• Revenue Growth: +10.18%
• P/S Ratio: 2.10
• Revenue / Employee: 1.18M CNY
• Employees: 24,379
• Market Cap: 8.02B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.87B	2.67B	10.18%
Dec 31, 2023	26.20B	173.25M	0.67%
Dec 31, 2022	26.03B	-835.19M	-3.11%
Dec 31, 2021	26.86B	3.21B	13.59%
Dec 31, 2020	23.65B	-586.81M	-2.42%